Skip to Content

Book Series

Chapman & Hall/CRC Biostatistics Series

Series Editor: Shein-Chung Chow, Karl E. Peace, Jen-pei Liu, Byron Jones, Bruce W. Turnbull

New and Published Books

1-10 of 70 results in Chapman & Hall/CRC Biostatistics Series
  1. Statistical Methods in Drug Combination Studies

    Edited by Wei Zhao, Harry Yang

    Series: Chapman & Hall/CRC Biostatistics Series

    The growing interest in using combination drugs to treat various complex diseases has spawned the development of many novel statistical methodologies. The theoretical development, coupled with advances in statistical computing, makes it possible to apply these emerging statistical methods in in...

    Published December 18th 2014 by Chapman and Hall/CRC

  2. Inference Principles for Biostatisticians

    By Ian C. Marschner

    Series: Chapman & Hall/CRC Biostatistics Series

    Designed for students training to become biostatisticians as well as practicing biostatisticians, Inference Principles for Biostatisticians presents the theoretical and conceptual foundations of biostatistics. It covers the theoretical underpinnings essential to understanding subsequent core...

    Published December 10th 2014 by Chapman and Hall/CRC

  3. Sample Size Calculations for Clustered and Longitudinal Outcomes in Clinical Research

    By Chul Ahn, Moonseoung Heo, Song Zhang

    Series: Chapman & Hall/CRC Biostatistics Series

    Accurate sample size calculation ensures that clinical studies have adequate power to detect clinically meaningful effects. This results in the efficient use of resources and avoids exposing a disproportionate number of patients to experimental treatments caused by an overpowered study. Sample...

    Published December 8th 2014 by Chapman and Hall/CRC

  4. Quantitative Evaluation of Safety in Drug Development

    Design, Analysis and Reporting

    Edited by Qi Jiang, H. Amy Xia

    Series: Chapman & Hall/CRC Biostatistics Series

    State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and...

    Published December 7th 2014 by Chapman and Hall/CRC

  5. Noninferiority Testing in Clinical Trials

    Issues and Challenges

    By Tie-Hua Ng

    Series: Chapman & Hall/CRC Biostatistics Series

    Take Your NI Trial to the Next Level Reflecting the vast research on noninferiority (NI) designs from the past 15 years, Noninferiority Testing in Clinical Trials: Issues and Challenges explains how to choose the NI margin as a small fraction of the therapeutic effect of the active control in a...

    Published November 30th 2014 by Chapman and Hall/CRC

  6. Adaptive Design Theory and Implementation Using SAS and R, Second Edition

    By Mark Chang

    Series: Chapman & Hall/CRC Biostatistics Series

    Get Up to Speed on Many Types of Adaptive Designs Since the publication of the first edition, there have been remarkable advances in the methodology and application of adaptive trials. Incorporating many of these new developments, Adaptive Design Theory and Implementation Using SAS and R, Second...

    Published November 30th 2014 by Chapman and Hall/CRC

  7. Mixed Effects Models for the Population Approach

    Models, Tasks, Methods and Tools

    By Marc Lavielle

    Series: Chapman & Hall/CRC Biostatistics Series

    Wide-Ranging Coverage of Parametric Modeling in Linear and Nonlinear Mixed Effects ModelsMixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools presents a rigorous framework for describing, implementing, and using mixed effects models. With these models, readers can...

    Published July 13th 2014 by Chapman and Hall/CRC

  8. Clinical and Statistical Considerations in Personalized Medicine

    Edited by Claudio Carini, Sandeep M Menon, Mark Chang

    Series: Chapman & Hall/CRC Biostatistics Series

    The Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances related to biomarkers and their translation into clinical development. Leading clinicians, biostatisticians, regulators,...

    Published March 26th 2014 by Chapman and Hall/CRC

  9. Patient-Reported Outcomes

    Measurement, Implementation and Interpretation

    By Joseph C. Cappelleri, Kelly H. Zou, Andrew G. Bushmakin, Jose Ma. J. Alvir, Demissie Alemayehu, Tara Symonds

    Series: Chapman & Hall/CRC Biostatistics Series

    Advancing the development, validation, and use of patient-reported outcome (PRO) measures, Patient-Reported Outcomes: Measurement, Implementation and Interpretation helps readers develop and enrich their understanding of PRO methodology, particularly from a quantitative perspective. Designed for...

    Published December 19th 2013 by Chapman and Hall/CRC

  10. Benefit-Risk Assessment in Pharmaceutical Research and Development

    Edited by Andreas Sashegyi, James Felli, Rebecca Noel

    Series: Chapman & Hall/CRC Biostatistics Series

    Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides...

    Published November 26th 2013 by Chapman and Hall/CRC